← Back to Discover

Trails Edge Capital Partners, LP

Period ended Jun 30, 2026 · Latest filing Aug 14, 2026

These quarterly holdings are delayed and may not include all assets or short positions. Values are from the reporting date, not current prices or purchase costs. The same security may appear in multiple rows.

Source: SEC

Reported portfolio value

Quarter-end reported holdings; not current value or investment performance.

View reported values
  • Jun 30, 2026: $629,911,888

More quarters will appear as history becomes available.

Top holdings

Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.

View top holdings values
  1. LB PHARMACEUTICALS INC · COM SHS · 50180M108 · shares: $49,429,679
  2. NURIX THERAPEUTICS INC · COM · 67080M103 · shares: $38,166,318
  3. IMMUNOCORE HLDGS PLC · ADS · 45258D105 · shares: $33,757,680
  4. FIRST TRACKS BIOTHERAPEUTICS · ORD SHS · 337185102 · shares: $30,461,680
  5. 4D MOLECULAR THERAPEUTICS IN · COM · 35104E100 · shares: $29,631,296
  6. BIOMARIN PHARMACEUTICAL INC · COM · 09061G101 · shares: $29,296,640
  7. DESIGN THERAPEUTICS INC · COM · 25056L103 · shares: $28,958,550
  8. XENON PHARMACEUTICALS INC · COM · 98420N105 · shares: $26,558,400
  9. MIRUM PHARMACEUTICALS INC · COM · 604749101 · shares: $26,143,136
  10. INSMED INC · COM PAR $.01 · 457669307 · shares: $24,557,891

Reported holdings

35 reported entries
IssuerClassCUSIPTypeShares / principalReported value (USD)
LB PHARMACEUTICALS INCCOM SHS50180M108 — 1,523,022 shares $49,429,679
NURIX THERAPEUTICS INCCOM67080M103 — 1,573,220 shares $38,166,318
IMMUNOCORE HLDGS PLCADS45258D105 — 1,063,234 shares $33,757,680
FIRST TRACKS BIOTHERAPEUTICSORD SHS337185102 — 1,514,000 shares $30,461,680
4D MOLECULAR THERAPEUTICS INCOM35104E100 — 2,227,917 shares $29,631,296
BIOMARIN PHARMACEUTICAL INCCOM09061G101 — 512,000 shares $29,296,640
DESIGN THERAPEUTICS INCCOM25056L103 — 2,001,282 shares $28,958,550
XENON PHARMACEUTICALS INCCOM98420N105 — 440,000 shares $26,558,400
MIRUM PHARMACEUTICALS INCCOM604749101 — 223,312 shares $26,143,136
INSMED INCCOM PAR $.01457669307 — 230,331 shares $24,557,891
CYTOKINETICS INCCOM NEW23282W605 — 288,089 shares $24,542,302
SYNDAX PHARMACEUTICALS INCCOM87164F105 — 1,110,000 shares $24,264,600
NEUROGENE INCCOM64135M105 — 714,885 shares $22,483,133
KAILERA THERAPEUTICS INCCOMMON STOCK482931102 — 984,786 shares $21,694,836
REVOLUTION MEDICINES INCCOM76155X100 — 115,750 shares $21,677,660
INHIBIKASE THERAPEUTICS INCCOM NEW45719W205 — 9,051,318 shares $18,374,176
INCYTE CORPCOM45337C102 — 155,000 shares $17,570,800
AVALO THERAPEUTICS INCCOM NEW05338F306 — 891,881 shares $16,481,961
MOONLAKE IMMUNOTHERAPEUTICSCLASS A ORD61559X104 — 750,000 shares $14,602,500
FAETH THERAPEUTICS INCCOM NEW81728A207 — 515,335 shares $12,883,375
X4 PHARMACEUTICALS INCCOM NEW98420X202 — 2,571,478 shares $12,008,803
OPUS GENETICS INCCOM67577R102 — 2,743,658 shares $11,276,434
SOL-GEL TECHNOLOGIES LTDSHS NEWM8694L137 — 139,445 shares $10,338,452
AURA BIOSCIENCES INCCOM05153U107 — 1,443,333 shares $10,247,665
CENTURY THERAPEUTICS INCCOM15673T100 — 4,134,969 shares $10,130,674
INVENTIVA SAADS46124U107 — 2,657,997 shares $10,047,228
CAMP4 THERAPEUTICS CORPCOM13463J101 — 1,932,937 shares $8,446,935
ALTIMMUNE INCCOM NEW02155H200 — 2,660,000 shares $8,086,400
MINERVA NEUROSCIENCES INCCOM NEW603380205 — 1,419,000 shares $7,875,450
PROMIS NEUROSCIENCES INCCOM SHS74346M505 — 557,103 shares $7,331,475
ONKURE THERAPEUTICS INCCOM CL A68277Q105 — 1,438,456 shares $6,559,359
FORTE BIOSCIENCES INCCOM NEW34962G208 — 273,181 shares $5,805,097
RESEARCH ALLIANCE CORP IIIORD SHS CL AG75226103 — 500,000 shares $5,350,000
VTV THERAPEUTICS INCCL A NEW918385204 — 85,192 shares $3,207,479
IMAGENEBIO INCCOM45175G207 — 282,004 shares $1,663,824